Symbol="GMDA"
AssetType="Common Stock"
Name="Gamida Cell Ltd"
Description="Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company is headquartered in Jerusalem, Israel."
CIK="1600847"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5 NAHUM HAFZADI STREET, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="148258000"
EBITDA="-75576000"
PERatio="None"
PEGRatio="None"
BookValue="-0.229"
DividendPerShare="0"
DividendYield="0"
EPS="-1.16"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.431"
ReturnOnEquityTTM="-16.66"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="7.35"
EVToRevenue="-"
EVToEBITDA="-1.506"
Beta="1.511"
num_52WeekHigh="3.03"
num_52WeekLow="0.56"
num_50DayMovingAverage="1.498"
num_200DayMovingAverage="1.533"
SharesOutstanding="121523000"
DividendDate="None"
ExDividendDate="None"
symbol="GMDA"
open="1.27"
high="1.27"
low="1.19"
price="1.22"
volume="1216827.00"
latest_trading_day="2023-08-25"
previous_close="1.25"
change="-0.03"
change_percent="-2.4000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="34"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="66"
Volume_recent_avg="3872464"
Change_recent_avg="0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="66"
Aroon_momentum_negative="34"
image_negative_thumbnail_id_1="1128"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0161.jpeg"
image_negative_thumbnail_id_2="132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0044.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="976"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_positive_thumbnail_id_2="685"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0023.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
